Drug industry’s great war over ‘Tamiflu’ generics with start of flu season
Ahead of a regular flu season, the drug industry has had a ‘great war’ over ‘Tamiflu’ generic medicines.
After the Roche’s influenza treatment Tamiflu’s patent was expired on the last 22nd of August, about 30 Korean pharmaceutical companies have acquired approval for approximately 100 Tamiflu ge...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
